Meet Our Experts

Meet our Dermatology Expert

Stefan Weiss, MD, MHSc, MBA

Dr. Weiss is the Managing Director of Dermatology at OM1. A leader in the field of dermatology, his career has spanned both health care delivery and life sciences. Previously, he was Senior Medical Director at a publicly held dermatology focused biotech during which time he secured multiple new drug approvals for the treatment of inflammatory skin diseases.

Dr. Weiss is a board certified dermatologist. He has served on several national medical advisory committees and has published widely on psoriasis and atopic dermatitis.

Dr. Weiss is a graduate of Yale University. He received his MD and MHSc in Clinical Research from the Duke University School of Medicine.

He completed residency training in dermatology at the Stanford University School of Medicine and a fellowship in Bioethics at the NIH. He holds an MBA from the Kellogg School of Management at Northwestern University.

Meet our Mental Health Expert

Carl Marci, MD

Dr. Carl Marci is the Chief Psychiatrist and Managing Director of Mental Health and Neuroscience at OM1. Previously, he was Chief Psychiatrist and Chief Medical Officer at several venture backed health and technology companies.

Dr. Marci is board certified and is part-time staff at Massachusetts General Hospital and Assistant Professor of Psychiatry at Harvard Medical School. He completed two NIH Fellowships in neuroscience and has published numerous articles in peer-review science journals. He holds seven patents and is author of a forthcoming book on the impact of technology on the brain.

Dr. Marci is a graduate of Columbia University and Oxford University where he was a Rhodes Scholar. He then went to Harvard Medical School and graduated with honors; he is also the former Director of Social Neuroscience at Massachusetts General Hospital.

Meet our RWE Research Expert

Kathryn Starzyk, ScM

Kathryn is the Vice President of Real World Evidence at OM1. Previously, she was the Senior Director of Epidemiology and Outcomes Research at Outcome (now part of the late phase division of IQVIA).

Prior to Outcome, she served as lead for safety and risk management for products from clinical development through to post-marketing, with particular expertise in rare diseases, biologics and gene therapy applications at Genzyme.

She has also held research positions at the NIH, Columbia and Harvard.

Kathryn is a graduate of Dartmouth College and the Harvard T.H. Chan School of Public Health.

Comprehensive Insights – Available Today

Psoriatic Arthritis
Rheumatoid Arthritis
Ankylosing Spondylitis
Schizophrenia

Psoriasis
Atopic Dermatitis
Bipolar Disorder 1
Major Depressive Disorder

PDF Report
PowerPoint Report
Bi-annual updates

Purchase stand-alone reports or bundle reports for cost optimization

Hundreds of medications to choose from
Option to include multiple medications